These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13719441)

  • 1. [The in-vitro heparin tolerance test in practice. II. The control of anticoagulant therapy].
    DALLA VOLTA S; FUSARO A
    Prog Med (Napoli); 1961 Apr; 17():223-30. PubMed ID: 13719441
    [No Abstract]   [Full Text] [Related]  

  • 2. [The test of heparin tolerance "in vitro"].
    FORTEZA BOVER G; PERIS MORA R; TORMO ALFONSO V; ALGARRA VIDAL F
    Rev Clin Esp; 1960 Oct; 79():38-44. PubMed ID: 13700898
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin resistance determined by the heparin tolerance test in patients treated with phenylindanedione before, during, and after operation.
    GORMSEN J; HAXHOLDT BF
    Acta Chir Scand; 1961; 121():367-76. PubMed ID: 13707283
    [No Abstract]   [Full Text] [Related]  

  • 4. [On blood hypercoagulability following the anticoagulant effect of heparin].
    BOCCARDI V; DERIU L
    Prog Med (Napoli); 1961 Sep; 17():607-14. PubMed ID: 13870323
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin tolerance and blood coagulation factors in obliterating arteriopathy].
    WALCHER A; GOOSSENS N; HESS H; STUMPF W
    Klin Wochenschr; 1960 Sep; 38():952. PubMed ID: 13782625
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the mechanism of heparin action on blood clotting and fibrinolysis].
    NIEWIAROWSKI S; WEGRZYNOWICZ Z
    Pol Tyg Lek; 1961 Jun; 16():901-5. PubMed ID: 13729010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the antilipemic and anticoagulant activity of a heparin derivative].
    REGAZZINI A; RODARI T
    Rass Fisiopatol Clin Ter; 1961 Apr; 33():301-16. PubMed ID: 14491056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with trypsin-heparin mixture with fibrinolytic action].
    SCARDIGLI G; GUIDI G; LOMBARDI V
    Minerva Med; 1961 Feb; 52():416-21. PubMed ID: 13747075
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the control of anticoagulant therapy by means of the heparin tolerance test in vitro].
    FUSARO A; DALLA VOLTA S
    Atti Soc Ital Cardiol; 1959; 21(2)():Comunicazioni 127-8. PubMed ID: 13825765
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of sodium dextrothyroxine in patients receiving anticoagulants.
    OWENS JC; NEELY WB; OWEN WR
    N Engl J Med; 1962 Jan; 266():76-9. PubMed ID: 14482918
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cephalin-heparin test. Proposed new test for control of anticoagulant therapy].
    Triginer J; Gomez-Granda LG; Fernandez Cavada JP; Quesada R
    Sangre (Barc); 1965; 10(3):245-54. PubMed ID: 5864587
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications and contraindications for anticoagulant therapy in the light of coagulation physiology].
    DE NICOLA P
    Schweiz Med Wochenschr; 1954 Jul; 84(29):835-8. PubMed ID: 13195640
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticoagulant therapy and Owren's thrombotest].
    DAINOTTO F; TOGNAZZI D; VIOLANTI A
    Haematologica; 1961; 46():141-60. PubMed ID: 13719368
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coagulation time in subcutaneous heparin treatment].
    von AHN
    Sven Lakartidn; 1959 Dec; 56():3409-16. PubMed ID: 13792141
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in blood coagulability induced by direct anticoagulants during treatment with anti-vitamin K].
    BIZZI B; ROSSI L
    Haematol Lat; 1961; 4():273-87. PubMed ID: 13869568
    [No Abstract]   [Full Text] [Related]  

  • 18. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of hypofibrinogenaemia and thrombosis.
    GORMSEN J
    Acta Chir Scand; 1961; 121():367-76. PubMed ID: 13707288
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.